| Product Name | MF | CAS | Details |
|---|
| Exendin (9-39) | C149H234N40O47S | 133514-43-9 | Details |
| (Glu1)-Fibrinopeptide B (human) | C66H95N19O26 | 103213-49-6 | Details |
| (Glu8.9)-Helodermin | C176H283N45O51 | 209340-47-6 | Details |
| Cyclo(-Arg-Ala-Asp-D-Phe-Cys) | C25H36N8O7S | 1055991-02-0 | Details |
| Fmoc-Ala-Ala-OH | C21H22N2O5 | 87512-31-0 | Details |
| Ac-Asp-Arg-Leu-Asp-Ser-OH | C25H42N8O12 | 153959-57-0 | Details |
| Fmoc-Pro-Phe-OH | C29H28N2O5 | 120943-07-9 | Details |
| Fmoc-Pro-Pro-Pro-Pro-OH | C35H40N4O7 | 454693-96-0 | Details |
| H-Arg-Gly-Asp-OH | C12H22N6O6 | 99896-85-2 | Details |
| Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala) | C25H40N10O10 | 128857-77-2 | Details |
| Eptifibatide | C35H49N11O9S2 | 188627-80-7 | Details |
| Fibronectin Fragment (1376-1380) | C24H39N11O8 | 158622-13-0 | Details |
| Fibronectin Fragment (1377-1388) | C56H97N19O20 | 162257-99-0 | Details |
| Exendin-4 (3-39) | C176H272N46O58S | 196109-31-6 | Details |
| PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) | Details |
| H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH | C28H49N11O11 | 111119-28-9 | Details |
| Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) sulfoxide | C26H36N8O11S | 143120-27-8 | Details |
| Cyclo(-Arg-Gly-Asp-D-Phe-Lys) | C27H41N9O7 | 161552-03-0 | Details |
| Cyclo(-Arg-Gly-Asp-D-Phe-Glu) | C26H36N8O9 | 756500-22-8 | Details |
| Phenylac-Leu-Asp-Phe-D-Pro-NH2 | C28H41N5O7 | 209601-16-1 | Details |
| Integrin Binding Peptide | C42H63N15O16S | 278792-07-7 | Details |
| FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH | C49H59N11O16S | 2022956-44-9 | Details |
| Exendin-3 | C184H282N50O61S | 130357-25-4 | Details |
| (Tyr15)-Fibrinopeptide B (human) | C75H102N20O27 | 125455-56-3 | Details |
| H-Gly-Arg-Gly-Glu-Ser-Pro-OH | C23H39N9O10 | 99896-88-5 | Details |
| H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH (Disulfide bond) | C41H61N13O15S2 | 166184-23-2 | Details |
| Galacto-RGD | C34H52N10O12 | 922175-70-0 | Details |
| Cyclo(-Arg-Gly-Asp-D-Phe-Cys) | C24H34N8O7S | 862772-11-0 | Details |
| H-Arg-Gly-Glu-OH | C13H24N6O6 | 20274-91-3 | Details |
| H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH | C29H51N11O11 | 125455-58-5 | Details |
| Fmoc-Nle-Nle-OH | C27H34N2O5 | 251316-91-3 | Details |
| Fmoc-Gly-Phe-OH | C26H24N2O5 | 117370-45-3 | Details |
| H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH (Disulfide bond between Pen2 and Cys) | C35H57N13O14S2 | 126716-28-7 | Details |
| Fmoc-Gly-Pro-Hyp-OH | C27H29N3O7 | 185213-75-6 | Details |
| RGD-targeted Proapoptotic Peptide | Details |
| H-Gly-Phe-Arg-Gly-Asp-Gly-Gln-OH | C30H45N11O11 | 148913-98-8 | Details |
| H-Lys-Gly-Glu-OH | C13H24N4O6 | 88096-12-2 | Details |
| H-Gly-Arg-Gly-Asp-Ser-Cys-OH | C20H35N9O10S | 91037-71-7 | Details |
| Ac-Pen-Arg-Gly-Asp-Cys-OH (Disulfide bond) | C22H36N8O9S2 | 135702-36-2 | Details |
| Bifunctional Antiplatelet Agent | C53H103N25O13 | 148796-92-3 | Details |
| H-Asp-Arg-Gly-Asp-Ser-OH | C19H32N8O11 | 151997-53-4 | Details |
| H-Ser-Asp-Gly-Arg-Gly-OH | C17H30N8O9 | 108608-63-5 | Details |
| H-Arg-Gly-Asp-Ser-Pro-OH | C20H34N8O9 | 110697-44-4 | Details |
| H-Lys-Gln-Ala-Gly-Asp-Val-OH | C25H44N8O10 | 80755-87-9 | Details |
| H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH | C25H42N10O11S | 91575-26-7 | Details |
| Cyclo(-Arg-Ala-Asp-D-Tyr-Lys) | C28H43N9O8 | 1193347-53-3 | Details |
| Fibronectin CS-1 Fragment (1978-1985) | C38H64N8O15 | 136466-51-8 | Details |
| Fibronectin Adhesion-Promoting Peptide | C47H74N16O10 | 125720-21-0 | Details |
| RGD-4C | C42H60N14O16S4 | 332179-76-7 | Details |
| H-Arg-Gly-Glu-Ser-OH | C16H29N7O8 | 93674-97-6 | Details |
| Echistatin | C217H341N71O74S9 | 154303-05-6 | Details |
| Fibronectin CS-1 Fragment (1978-1982) | C26H45N5O10 | 150525-67-0 | Details |
| H-Gly-Arg-Gly-Asp-Ser-Pro-OH | C22H37N9O10 | 91037-75-1 | Details |
| Fmoc-Phe-Arg-OH | C30H33N5O5 | 250695-64-8 | Details |
| H-Lys-Gly-Asp-Ser-OH | C15H27N5O8 | 93674-95-4 | Details |
| H-Pro-Ser-Hyp-Gly-Asp-Trp-OH | C30H39N7O11 | 163722-91-6 | Details |
| Cyclo(-Arg-Ala-Asp-D-Phe-Lys) | C28H43N9O7 | 756500-23-9 | Details |
| H-Tyr-Arg-Gly-Asp-Ser-OH | C24H36N8O10 | 134282-68-1 | Details |
| H-Gly-Arg-Gly-Asp-Ser-OH | C17H30N8O9 | 96426-21-0 | Details |
| H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH | C22H37N9O10 | 111844-24-7 | Details |
| Fibronectin Fragment (196-203) | C35H62N18O14S | 150525-72-7 | Details |
| H-Arg-Gly-Asp-Cys-OH | C15H27N7O7S | 109292-46-8 | Details |
| H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH | C40H68N14O16 | 91575-25-6 | Details |
| H-Gly-Arg-Gly-Asp-OH | C14H25N7O7 | 97461-81-9 | Details |
| Fibrinopeptide A (human) | C63H97N19O26 | 25422-31-5 | Details |
| Fmoc-Phe-Phe-OH | C33H30N2O5 | 84889-09-8 | Details |
| H-Gly-Arg-Gly-Asp-Asn-Pro-OH | C23H38N10O10 | 114681-65-1 | Details |
| Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH | C33H55N11O12S | 2022956-45-0 | Details |
| Exendin-4 (1-8) | C35H51N11O13 | 1802078-29-0 | Details |
| (4-((2-Methylphenyl)aminocarbonyl)-aminophenyl)acetyl-Fibronectin CS-1 Fragment (1980-1983) | C36H48N6O9 | 187735-94-0 | Details |
| Fmoc-Gly-Gly-Gly-OH | C21H21N3O6 | 170941-79-4 | Details |
| (Tyr0)-Fibrinopeptide A (human) | C72H106N20O28 | 103226-11-5 | Details |
| Cyclo(-Arg-Ala-Asp-D-Phe-Val) | C27H40N8O7 | 137813-36-6 | Details |
| Fibronectin Fragment (1954-1959) | C32H63N11O7 | 184895-13-4 | Details |
| (Glu9)-Exenatide (2-39) | 196109-34-9 | Details |
| Cyclo(-Arg-Gly-Asp-D-Phe-Val) | C26H38N8O7 | 137813-35-5 | Details |
| Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) | C22H35N9O9 | 135432-37-0 | Details |
| Fmoc-Gly-Val-OH | C22H24N2O5 | 86895-14-9 | Details |
| Cilengitide | C27H40N8O7 | 188968-51-6 | Details |
| Helodermin | C176H285N47O49 | 89468-62-2 | Details |
| H-Gly-Arg-Gly-Asp-Thr-Pro-OH | C23H39N9O10 | 108682-58-2 | Details |
| Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) | C27H41N9O8 | 217099-14-4 | Details |
| H-Gly-Arg-Gly-Glu-Ser-OH | C18H32N8O9 | 97461-84-2 | Details |
| Fibrinopeptide B (human) | C66H93N19O25 | 36204-23-6 | Details |
| Met(O)14-Exenatide | 1678417-38-3 | Details |
| H-Gly-Arg-Gly-Asp-Ser-NH2 | C17H31N9O8 | 143648-02-6 | Details |
| H-Arg-Gly-Asp-Ser-OH | C15H27N7O8 | 91037-65-9 | Details |
| H-D-Arg-Gly-Asp-Trp-OH | C23H32N8O7 | 144161-76-2 | Details |
| Fmoc-D-Pro-D-Pro-D-Pro-D-Pro-OH | C35H40N4O7 | 1926163-34-9 | Details |
| Fmoc-Pro-Pro-Pro-OH | C30H33N3O6 | 134303-96-1 | Details |
| H-Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr-OH | C52H76N14O20S | 94040-53-6 | Details |
| H-Gly-Arg-Ala-Asp-Ser-Pro-OH | C23H39N9O10 | 99896-86-3 | Details |
| Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro) | C23H37N9O9 | 2022956-43-8 | Details |
| Fmoc-Phe-Ser(tBu)-OH | C31H34N2O6 | 157675-78-0 | Details |
| H-Arg-Gly-Asp-Val-OH | C17H31N7O7 | 93674-99-8 | Details |
| H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys) | C59H87N19O16 | 250612-47-6 | Details |
| H-Arg-Phe-Asp-Ser-OH | C22H33N7O8 | 102567-19-1 | Details |
| RGD Negative Control | C27H38N8O9 | 756500-24-0 | Details |
| Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) | C23H32N8O7 | 153381-95-4 | Details |
| H-Lys-Asn-Asn-Gln-Lys-Ser-Glu-Pro-Leu-Ile-Gly-Arg-Lys-Lys-Thr-OH | C74H133N25O23 | 111793-75-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 | ||||